Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Apotex Inc. v. Eli Lilly & Co., IPR2016-01190 (PTAB) July 1, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Apotex Inc. v. Eli Lilly & Co., IPR2016-01191 (PTAB) July 1, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01340 (PTAB) July 1, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01341 (PTAB) July 1, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01343 (PTAB) July 1, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Orexo AB v. Actavis Elizabeth LLC, 16-0582 (D. Del.) July 7, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride sublingual tablets) 9,259,421
AstraZeneca AB v. Apotex Corp., 16-0583 (D. Del.) July 7, 2016 Hon. Gregory M. Sleet Onglyza® (saxagliptin hydrochloride tablets) RE44,186
Mallinckrodt Hospital Products IP Ltd. v. Praxair Distribution Inc., 16-0592 (D. Del.) July 8, 2016 Hon. Gregory M. Sleet INOmax® (nitric oxide for inhalation)
9,265,911
9,295,802
9,279,794
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd., 16-4178 (D.N.J.) July 8, 2016 Hon. Renee Marie Bumb Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
6,642,245
6,703,396
8,592,397
8,716,264
Mylan Inc. v. Dr. Falk Pharma GmbH, IPR2016-01386 (PTAB) July 8, 2016 N/A Apriso® (mesalamine extended-release capsules) 8,865,688
Teva Pharms. USA, Inc. v. Eli Lilly & Co., IPR2016-01393 (PTAB) July 8, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Imprimis Pharms., Inc. v. Alcon Pharms. Ltd., 16-1794 (S.D. Cal.) July 11, 2016 Hon. Marilyn L. Huff
Vigamox® (moxifloxacin hydrochloride ophthalmic solution)

Moxeza® (moxifloxacin hydrochloride ophthalmic solution)
6,716,830
7,671,070
Fohill Capital Partners v. Dr. Falk Pharma GmbH, IPR2016-01409 (PTAB) July 11, 2016 N/A Apriso® (mesalamine extended-release capsules) 8,865,688
Tris Pharma, Inc. v. Actavis Elizabeth LLC, 16-0603 (D. Del.) July 12, 2016 Hon. Gregory M. Sleet QuilliChew ER® (methylphenidate hydrochloride extended-release chewable tablets)
8,202,537
8,287,903
8,999,386
9,295,642
Helsinn Healthcare S.A. v. Zydus Pharms. (USA) Inc., 16-4239 (D.N.J.) July 12, 2016 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride injection)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Amneal Pharms. LLC v. Yeda Research & Development Co. Ltd., PGR2016-00028 (PTAB) July 12, 2016 N/A Copaxone® (glatiramer acetate injection) 9,155,776
Actavis Elizabeth LLC v. Novartis Pharms. Corp., 16-0604 (D. Del.) July 13, 2016 Hon. Richard G. Andrews Jadenu® (deferasirox tablets) 9,283,209
Shionogi Inc. v. Actavis Labs. UT, Inc., 16-0606 (D. Del.) July 14, 2016 Hon. Leonard P. Stark Ulesfia® (benzyl alcohol lotion)
6,793,931
7,294,342
Apotex Inc. v. Eli Lilly & Co., IPR2016-01429 (PTAB) July 14, 2016 N/A Alimta® (pemetrexed disodium for injection) 7,772,209
Valeant Pharms. Luxembourg S.A.R.L. v. Actavis Labs. UT, Inc., 16-4344 (D.N.J.) July 15, 2016 Hon. Jose L. Linares Carac® (fluorouracil topical cream) 6,670,335
Amneal Pharms. LLC v. Purdue Pharma L.P., IPR2016-01412 (PTAB) July 15, 2016 N/A OxyContin® (oxycodone hydrochloride extended-release tablets) 9,034,376
Amneal Pharms. LLC v. Purdue Pharma L.P., IPR2016-01413 (PTAB) July 15, 2016 N/A OxyContin® (oxycodone hydrochloride extended-release tablets) 9,034,376
Roxane Labs., Inc. v. Novartis AG, IPR2016-01461 (PTAB) July 19, 2016 N/A Afinitor® (everolimus tablets) 9,006,224
Allergan, Inc. v. TWi Pharms., Inc., 16-0620 (D. Del.) July 20, 2016 Hon. Gregory M. Sleet Restasis® (cyclosporine ophthalmic emulsion)
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
9,248,191
AstraZeneca AB v. Aurobindo Pharma Ltd., 16-4414 (D.N.J.) July 20, 2016 Hon. Mary L. Cooper Nexium® 24HR (esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
Koios Pharms. LLC v. Medac Gesellschaft für klinische Spezialpräparate mbH, IPR2016-01370 (PTAB) July 20, 2016 N/A Rasuvo® (methotrexate solution) 8,664,231
Horizon Therapeutics, Inc. v. Lupin Ltd., 16-4438 (D.N.J.) July 21, 2016 Hon. Robert B. Kugler Ravicti® (glycerol phenylbutyrate oral solution)
9,254,278
9,326,966
Allergan, Inc. v. TWi Pharms., Inc., 16-0820 (E.D. Tex.) July 21, 2016 Hon. William C. Bryson Restasis® (cyclosporine ophthalmic emulsion)
8,629,111
8,633,162
8,642,556
8,648,048
8,685,930
9,248,191
Par Pharm., Inc. v. Novartis AG, IPR2016-01479 (PTAB) July 22, 2016 N/A Afinitor® (everolimus tablets) 9,006,224
Bayer Intellectual Property GmbH v. Breckenridge Pharm., Inc., 16-0628 (D. Del.) July 25, 2016 Hon. Sue L. Robinson Xarelto® (rivaroxaban tablets)
7,157,456
7,592,339
Fustibal LLC v. Bayer HealthCare, LLC, IPR2016-01490 (PTAB) July 25, 2016 N/A Stivarga® (regorafenib tablets) 8,637,553
Vivus, Inc. v. Hetero USA, Inc., 16-4560 (D.N.J.) July 27, 2016 Hon. Katharine S. Hayden Stendra® (avanafil tablets)
6,656,935
7,501,409
Sumitomo Dainippon Pharma Co., Ltd. v. Amneal Pharms. LLC, 16-4596 (D.N.J.) July 29, 2016 Hon. Stanley R. Chesler Latuda® (lurasidone hydrochloride tablets) 5,532,372
Novartis Pharms. Corp. v. Teva Pharms. USA, Inc., 16-0648 (D. Del.) July 29, 2016 Hon. Richard G. Andrews Jadenu® (deferasirox tablets) 6,465,504
AstraZeneca Pharms. LP v. Mylan Institutional LLC, 16-4612 (D.N.J.) July 29, 2016 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection)
6,774,122
7,456,160
8,329,680
8,466,139
Galderma Labs., L.P. v. Taro Pharms. U.S.A., Inc., 16-2207 (N.D. Tex.) July 29, 2016 Hon. Ed Kinkeade Epiduo® Forte (adapalene / benzoyl peroxide gel)
8,445,543
8,785,420
8,809,305
AstraZeneca Pharms. LP v. Mylan Institutional LLC, 16-0669 (D. Del.) Aug. 5, 2016 Hon. Richard G. Andrews Faslodex® (fulvestrant for injection)
6,774,122
7,456,160
8,329,680
8,466,139
Shionogi Inc. v. Hi-Tech Pharmacal Co., Inc., 16-0676 (D. Del.) Aug. 8, 2016 Hon. Leonard P. Stark Ulesfia® (benzyl alcohol lotion)
6,793,931
7,294,342
Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01563 (PTAB) Aug. 10, 2016 N/A
Tradjenta® (linagliptin tablets)

Jentadueto® (linagliptin / metformin hydrochloride tablets)
8,673,927
Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01564 (PTAB) Aug. 10, 2016 N/A
Tradjenta® (linagliptin tablets)

Jentadueto® (linagliptin / metformin hydrochloride tablets)
8,846,695
Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01565 (PTAB) Aug. 10, 2016 N/A
Tradjenta® (linagliptin tablets)

Jentadueto® (linagliptin / metformin hydrochloride tablets)
8,853,156
Mylan Pharms. Inc. v. Boehringer Ingelheim International GMBH, IPR2016-01566 (PTAB) Aug. 10, 2016 N/A
Tradjenta® (linagliptin tablets)

Jentadueto® (linagliptin / metformin hydrochloride tablets)
9,173,859
Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01577 (PTAB) Aug. 10, 2016 N/A Precedex® (dexmedetomidine hydrochloride for injection) 8,242,158
Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01578 (PTAB) Aug. 10, 2016 N/A Precedex® (dexmedetomidine hydrochloride for injection) 8,338,470
Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01579 (PTAB) Aug. 10, 2016 N/A Precedex® (dexmedetomidine hydrochloride for injection) 8,455,527
Amneal Pharms. LLC v. Hospira, Inc., IPR2016-01580 (PTAB) Aug. 10, 2016 N/A Precedex® (dexmedetomidine hydrochloride for injection) 8,648,106
Wockhardt Bio AG v. Janssen Oncology, Inc., IPR2016-01582 (PTAB) Aug. 10, 2016 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Lupin Atlantis Holdings, S.A. v. InvaGen Pharms., Inc., 16-0708 (D. Del.) Aug. 11, 2016 Hon. Sue L. Robinson Antara® (fenofibrate capsules)
8,026,281
9,314,447
Horizon Pharma, Inc. v. Actavis Labs. FL., Inc., 16-4916 (D.N.J.) Aug. 11, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,945,621
9,220,698
9,345,695
Horizon Pharma, Inc. v. Dr. Reddy’s Labs. Inc., 16-4918 (D.N.J.) Aug. 11, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,945,621
9,220,698
9,345,695
Horizon Pharma, Inc. v. Lupin Ltd., 16-4920 (D.N.J.) Aug. 11, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,945,621
9,220,698
9,345,695
Horizon Pharma, Inc. v. Mylan Pharms. Inc., 16-4921 (D.N.J.) Aug. 11, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,945,621
9,220,698
9,345,695
Gilead Sciences, Inc. v. Hetero Drugs Ltd., 16-4938 (D.N.J.) Aug. 11, 2016 Hon. Renee Marie Bumb Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets)
6,642,245
6,703,396
8,592,397
8,716,264
Jazz Pharms., Inc. v. Roxane Labs., Inc., 16-4971 (D.N.J.) Aug. 12, 2016 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 8,731,963
Lupin Atlantis Holdings, S.A. v. InvaGen Pharms., Inc., 16-4535 (E.D.N.Y.) Aug. 12, 2016 Hon. Brian M. Cogan Antara® (fenofibrate capsules)
8,026,281
9,314,447
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 16-5051 (D.N.J.) Aug. 18, 2016 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,339,551
9,339,552
9,375,412
9,370,501
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 16-5054 (D.N.J.) Aug. 18. 2016 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,339,551
9,339,552
9,375,412
9,370,501
Aurobindo Pharma Ltd. v. AstraZeneca AB, 16-5079 (D.N.J.) Aug. 18, 2016 Hon. Mary L. Cooper Prilosec OTC® (omeprazole magnesium delayed release tablets)
6,403,616
6,428,810
Torrent Pharms. Ltd. v. UCB Pharma GMBH, IPR2016-01636 (PTAB) Aug. 18, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 6,858,650
Apotex Inc. v. Alcon Research, Ltd., IPR2016-01640 (PTAB) Aug. 18, 2016 N/A Pazeo® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Galderma Labs., L.P. v. Perrigo UK Finco L.P., 16-0732 (D. Del.) Aug. 19, 2016 Hon. Leonard P. Stark Mirvaso® Gel (brimonidine topical gel)
7,439,241
8,426,410
8,859,551
8,410,102
8,513,247
8,513,249
Reckitt Benckiser LLC v. Sun Pharm. Indus., Ltd., 16-5133 (D.N.J.) Aug. 22, 2016 Hon. Renee Marie Bumb Mucinex® (guaifenesin extended-release tablets)
6,372,252
6,955,821
7,838,032
Alembic Pharms. Ltd. v. UCB Pharma GMBH, IPR2016-01596 (PTAB) Aug. 22, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 6,858,650
Amerigen Pharms. Ltd. v. UCB Pharma GMBH, IPR2016-01665 (PTAB) Aug. 22, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 6,858,650
Shire Development LLC v. Alkem Labs. Ltd., 16-0747 (D. Del.) Aug. 24, 2016 Hon. Leonard P. Stark Fosrenol® (lanthanum carbonate oral powder)
5,968,976
7,465,465
8,980,327
9,023,397
Otsuka Pharm. Co., Ltd. v. Ajanta Pharma Ltd., 16-5288 (D.N.J.) Aug. 29, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Galdrema Labs., L.P. v. Seegpharm S.A., 16-2497 (N.D. Tex.) Aug. 29, 2016 Hon. David C. Godbey MetroGel® (metronidazole topical gel)
6,881,726
7,348,317
Neos Therapeutics, Inc. v. Actavis Labs. FL, Inc., 16-0766 (D. Del.) Sept. 1, 2016 Hon. Gregory M. Sleet Adzenys XR-ODT™ (amphetamine extended-release orally disintegrating tablets)
8,709,491
8,840,924
9,017,731
9,265,737
Otsuka Pharm. Co., Ltd. v. Macleods Pharms. Ltd., 16-5400 (D.N.J.) Sept. 2, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Eli Lilly and Co. v. Sun Pharma Indus. Ltd., 16-0518 (E.D. Va.) Sept. 2, 2016 Hon. Raymond A. Jackson Cialis® (tadalafil tablets) 6,943,166
Eli Lilly and Co. v. Teva Pharms. (USA) Inc., 16-0519 (E.D. Va.) Sept. 2, 2016 Hon. Raymond A. Jackson Cialis® (tadalafil tablets) 6,943,166
Eli Lilly and Co. v. Zydus Pharms. (USA), Ltd., 16-0520 (E.D. Va.) Sept. 2, 2016 Hon. Raymond A. Jackson Cialis® (tadalafil tablets) 6,943,166
Eli Lilly and Co. v. Actavis Labs. UT, Inc., 16-1119 (E.D. Va.) Sept. 2, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
Eli Lilly and Co. v. Alembic Pharms. Ltd., 16-1120 (E.D. Va.) Sept. 2, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
Eli Lilly and Co. v. Aurobindo Pharma Ltd., 16-1121 (E.D. Va.) Sept. 2, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
Eli Lilly and Co. v. Mylan Pharms. Inc., 16-1122 (E.D. Va.) Sept. 2, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
West-Ward Pharms. Corp. v. Par Pharm. Inc., 16-5456 (D.N.J.) Sept. 8, 2016 Hon. Brian R. Martinotti Mitigare® (colchicine capsules) 8,927,607
Meda Pharms. Inc. v. Perrigo UK Finco Ltd. Partnership, 16-0794 (D. Del.) Sept. 9, 2016 Hon. Leonard P. Stark Dymista® (azelastine hydrochloride / fluticasone propionate nasal spray)
8,168,620
9,259,428
Unimed Pharms., LLC v. TWi Pharms., Inc., 16-0810 (D. Del.) Sept. 16, 2016 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp., 16-0812 (D. Del.) Sept. 16, 2016 Hon. Richard G. Andrews Lantus® / Lantus® SoloSTAR® (insulan glargine for injection)
7,918,833
8,512,297
8,556,864
8,603,044
8,992,486
8,679,069
9,011,391
9,233,211
7,476,652
7,713,930
Sanofi-Aventis U.S. LLC v. Sandoz Inc., 16-5678 (D.N.J.) Sept. 16, 2016 Hon. Michael A. Shipp Jevtana® Kit (cabazitaxel for injection)
5,847,170
8,927,592
Otsuka Pharm. Co., Ltd. v. Orchid Pharma Ltd., 16-5688 (D.N.J.) Sept. 16, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 16-5743 (D.N.J.) Sept. 19, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
9,359,302
9,387,182
Genzyme Corp. v. Mylan Labs. Ltd., 16-5828 (D.N.J.) Sept. 19, 2016 Hon. Stanley R. Chesler Clolar® (clofarabine for injection) 5,661,136
Amgen Inc. v. Aurobindo Pharma Ltd., 16-0853 (D. Del.) Sept. 22, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Micro Labs Ltd., 16-0854 (D. Del.) Sept. 22, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Watson Labs., Inc., 16-0855 (D. Del.) Sept. 22, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Eli Lilly and Co. v. Cipla Ltd., 16-1208 (E.D. Va.) Sept. 22, 2016 Hon. Anthony J. Trenga Cialis® (tadalafil tablets) 6,943,166
Impax Labs., Inc. v. Par Pharm., Inc., 16-0856 (D. Del.) Sept. 23, 2016 Hon. Richard G. Andrews Zomig® (zolmitriptan nasal spray) 7,220,767
Otsuka Pharm. Co., Ltd. v. Macleods Pharms. Ltd., 16-5949 (D.N.J.) Sept. 23, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,387,182
Genzyme Corp. v. Mylan Labs. Ltd., 16-0188 (N.D.W.V.) Sept. 23, 2016 Hon. Irene M. Keeley Clolar® (clofarabine for injection) 5,661,136
Otsuka Pharm. Co., Ltd. v. Alkem Labs. Ltd., 16-6067 (D.N.J.) Sept. 26, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,359,302
Silvergate Pharms., Inc. v. Bionpharma, Inc., 16-0876 (D. Del.) Sept. 28, 2016 Hon. Sue L. Robinson Epaned® (enalapril maleate for oral solution) 8,568,747
Hospira, Inc. v. Par Sterile Products, LLC, 16-0879 (D. Del.) Sept. 29, 2016 Hon. Richard G. Andrews Precedex® (dexmedetomidine hydrochloride for injection)
8,242,158
8,338,470
8,455,527
8,648,106
Amgen Inc. v. Cipla Ltd., 16-0880 (D. Del.) Sept. 29, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Strides Pharma Global PTE Ltd., 16-0881 (D. Del.) Sept. 29, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Amgen Inc. v. Sun Pharm. Indus., Ltd., 16-0882 (D. Del.) Sept. 29, 2016 Hon. Gregory M. Sleet Sensipar® (cinacalcet hydrochloride tablets) 9,375,405
Adare Pharms., Inc. v. Apotex, Inc., 16-0884 (D. Del.) Sept. 29, 2016 Hon. Sue L. Robinson Amrix® (cyclobenzaprine hydrochloride extended-release capsules) 9,399,025
Pfizer Inc. v. Aurobindo Pharma Ltd., 16-0886 (D. Del.) Sept. 30, 2016 Hon. Gregory M. Sleet Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
Arena Pharms., Inc. v. Lupin Ltd., 16-0887 (D. Del.) Sept. 30, 2016 Hon. Richard G. Andrews Belviq® (lorcaserin hydrochloride tablets)
6,953,787
7,514,422
7,977,329
8,207,158
8,273,734
8,546,379
8,575,149
8,999,970
9,169,213

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.